Laura M de Jong

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Cancer Stem Cells

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Menno Hoekstra, Laura M de Jong, Rick van der Geest, Lidewij R de Leeuw, Rani Krisnamurthi, Janine J Geerling, Miranda Van Eck
LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice. Biomolecules 14 (4) (2024)
Menno Hoekstra, Laura M de Jong, Rick van der Geest, Lidewij R de Leeuw, Rani Krisnamurthi, Janine J Geerling, Miranda Van Eck
LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice. Biomolecules 14 (4) (2024)
Menno Hoekstra, Laura M de Jong, Rick van der Geest, Lidewij R de Leeuw, Rani Krisnamurthi, Janine J Geerling, Miranda Van Eck
LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice. Biomolecules 14 (4) (2024)
Laura M de Jong, Sylvia D Klomp, Nicoline Treijtel, Robert Rissmann, Jesse Joachim Swen, Martijn L Manson
A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling. British journal of clinical pharmacology 88 (10) (2022)
Laura M de Jong, Wim Jiskoot, Jesse Joachim Swen, Martijn L Manson
Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics. Genes 11 (12) (2020)